Selected research
Industry Growth & Trends
Global Analgesic Creams Industry Growth and Trends Forecast to 2032
Market perspective
The global Analgesic Creams market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Analgesic Creams is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Analgesic Creams is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Analgesic Creams is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Analgesic Creams include Sanofi, Johnson & Johnson, Novartis, Mylan, Lingrui, Huarun 999, GSK, Topical BioMedics and THE PURE SOURCE, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Analgesic Creams market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Analgesic Creams market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Analgesic Creams market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Analgesic Creams.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Analgesic Creams market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Analgesic Creams Market by Company
Sanofi
Johnson & Johnson
Novartis
Mylan
Lingrui
Huarun 999
GSK
Topical BioMedics
THE PURE SOURCE
Teikoku Seiyaku
Qizheng
Mercury Healthcare
Hisamitsu
Endo
Actavis
Analgesic Creams Segment by Type
OTC
RX
Analgesic Creams Segment by Application
Muscle Pain
Arthritis Pain
Analgesic Creams Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Analgesic Creams market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Analgesic Creams and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Analgesic Creams.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Analgesic Creams manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Analgesic Creams in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- OTC
- RX
Applications
- Muscle Pain
- Arthritis Pain
Companies covered
- Sanofi
- Johnson & Johnson
- Novartis
- Mylan
- Lingrui
- Huarun 999
- GSK
- Topical BioMedics
- THE PURE SOURCE
- Teikoku Seiyaku
- Qizheng
- Mercury Healthcare
- Hisamitsu
- Endo
- Actavis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Analgesic Creams Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Analgesic Creams Sales Estimates and Forecasts (2021-2032)
- 1.3 Analgesic Creams Market by Type
- 1.3.1 OTC
- 1.3.2 RX
- 1.4 Global Analgesic Creams Market Size by Type
- 1.4.1 Global Analgesic Creams Market Size Overview by Type (2021-2032)
- 1.4.2 Global Analgesic Creams Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Analgesic Creams Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Analgesic Creams Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Analgesic Creams Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Analgesic Creams Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Analgesic Creams Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Analgesic Creams Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Analgesic Creams Industry Trends
- 2.2 Analgesic Creams Industry Drivers
- 2.3 Analgesic Creams Industry Opportunities and Challenges
- 2.4 Analgesic Creams Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Analgesic Creams Revenue (2021-2026)
- 3.2 Global Top Players by Analgesic Creams Sales (2021-2026)
- 3.3 Global Top Players by Analgesic Creams Price (2021-2026)
- 3.4 Global Analgesic Creams Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Analgesic Creams Major Company Production Sites & Headquarters
- 3.6 Global Analgesic Creams Company, Product Type & Application
- 3.7 Global Analgesic Creams Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Analgesic Creams Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Analgesic Creams Players Market Share by Revenue in 2025
- 3.8.3 2025 Analgesic Creams Tier 1, Tier 2, and Tier 3
4 Analgesic Creams Regional Status and Outlook
- 4.1 Global Analgesic Creams Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Analgesic Creams Historic Market Size by Region
- 4.2.1 Global Analgesic Creams Sales in Volume by Region (2021-2026)
- 4.2.2 Global Analgesic Creams Sales in Value by Region (2021-2026)
- 4.2.3 Global Analgesic Creams Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Analgesic Creams Forecasted Market Size by Region
- 4.3.1 Global Analgesic Creams Sales in Volume by Region (2027-2032)
- 4.3.2 Global Analgesic Creams Sales in Value by Region (2027-2032)
- 4.3.3 Global Analgesic Creams Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Analgesic Creams by Application
- 5.1 Analgesic Creams Market by Application
- 5.1.1 Muscle Pain
- 5.1.2 Arthritis Pain
- 5.2 Global Analgesic Creams Market Size by Application
- 5.2.1 Global Analgesic Creams Market Size Overview by Application (2021-2032)
- 5.2.2 Global Analgesic Creams Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Analgesic Creams Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Analgesic Creams Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Analgesic Creams Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Analgesic Creams Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Analgesic Creams Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Analgesic Creams Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Sanofi
- 6.1.1 Sanofi Company Information
- 6.1.2 Sanofi Business Overview
- 6.1.3 Sanofi Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Sanofi Analgesic Creams Product Portfolio
- 6.1.5 Sanofi Recent Developments
- 6.2 Johnson & Johnson
- 6.2.1 Johnson & Johnson Company Information
- 6.2.2 Johnson & Johnson Business Overview
- 6.2.3 Johnson & Johnson Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Johnson & Johnson Analgesic Creams Product Portfolio
- 6.2.5 Johnson & Johnson Recent Developments
- 6.3 Novartis
- 6.3.1 Novartis Company Information
- 6.3.2 Novartis Business Overview
- 6.3.3 Novartis Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Novartis Analgesic Creams Product Portfolio
- 6.3.5 Novartis Recent Developments
- 6.4 Mylan
- 6.4.1 Mylan Company Information
- 6.4.2 Mylan Business Overview
- 6.4.3 Mylan Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Mylan Analgesic Creams Product Portfolio
- 6.4.5 Mylan Recent Developments
- 6.5 Lingrui
- 6.5.1 Lingrui Company Information
- 6.5.2 Lingrui Business Overview
- 6.5.3 Lingrui Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Lingrui Analgesic Creams Product Portfolio
- 6.5.5 Lingrui Recent Developments
- 6.6 Huarun 999
- 6.6.1 Huarun 999 Company Information
- 6.6.2 Huarun 999 Business Overview
- 6.6.3 Huarun 999 Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Huarun 999 Analgesic Creams Product Portfolio
- 6.6.5 Huarun 999 Recent Developments
- 6.7 GSK
- 6.7.1 GSK Company Information
- 6.7.2 GSK Business Overview
- 6.7.3 GSK Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 GSK Analgesic Creams Product Portfolio
- 6.7.5 GSK Recent Developments
- 6.8 Topical BioMedics
- 6.8.1 Topical BioMedics Company Information
- 6.8.2 Topical BioMedics Business Overview
- 6.8.3 Topical BioMedics Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Topical BioMedics Analgesic Creams Product Portfolio
- 6.8.5 Topical BioMedics Recent Developments
- 6.9 THE PURE SOURCE
- 6.9.1 THE PURE SOURCE Company Information
- 6.9.2 THE PURE SOURCE Business Overview
- 6.9.3 THE PURE SOURCE Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 THE PURE SOURCE Analgesic Creams Product Portfolio
- 6.9.5 THE PURE SOURCE Recent Developments
- 6.10 Teikoku Seiyaku
- 6.10.1 Teikoku Seiyaku Company Information
- 6.10.2 Teikoku Seiyaku Business Overview
- 6.10.3 Teikoku Seiyaku Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Teikoku Seiyaku Analgesic Creams Product Portfolio
- 6.10.5 Teikoku Seiyaku Recent Developments
- 6.11 Qizheng
- 6.11.1 Qizheng Company Information
- 6.11.2 Qizheng Business Overview
- 6.11.3 Qizheng Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Qizheng Analgesic Creams Product Portfolio
- 6.11.5 Qizheng Recent Developments
- 6.12 Mercury Healthcare
- 6.12.1 Mercury Healthcare Company Information
- 6.12.2 Mercury Healthcare Business Overview
- 6.12.3 Mercury Healthcare Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Mercury Healthcare Analgesic Creams Product Portfolio
- 6.12.5 Mercury Healthcare Recent Developments
- 6.13 Hisamitsu
- 6.13.1 Hisamitsu Company Information
- 6.13.2 Hisamitsu Business Overview
- 6.13.3 Hisamitsu Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Hisamitsu Analgesic Creams Product Portfolio
- 6.13.5 Hisamitsu Recent Developments
- 6.14 Endo
- 6.14.1 Endo Company Information
- 6.14.2 Endo Business Overview
- 6.14.3 Endo Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Endo Analgesic Creams Product Portfolio
- 6.14.5 Endo Recent Developments
- 6.15 Actavis
- 6.15.1 Actavis Company Information
- 6.15.2 Actavis Business Overview
- 6.15.3 Actavis Analgesic Creams Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Actavis Analgesic Creams Product Portfolio
- 6.15.5 Actavis Recent Developments
7 North America by Country
- 7.1 North America Analgesic Creams Sales by Country
- 7.1.1 North America Analgesic Creams Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Analgesic Creams Sales by Country (2021-2026)
- 7.1.3 North America Analgesic Creams Sales Forecast by Country (2027-2032)
- 7.2 North America Analgesic Creams Market Size by Country
- 7.2.1 North America Analgesic Creams Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Analgesic Creams Market Size by Country (2021-2026)
- 7.2.3 North America Analgesic Creams Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Analgesic Creams Sales by Country
- 8.1.1 Europe Analgesic Creams Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Analgesic Creams Sales by Country (2021-2026)
- 8.1.3 Europe Analgesic Creams Sales Forecast by Country (2027-2032)
- 8.2 Europe Analgesic Creams Market Size by Country
- 8.2.1 Europe Analgesic Creams Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Analgesic Creams Market Size by Country (2021-2026)
- 8.2.3 Europe Analgesic Creams Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Analgesic Creams Sales by Country
- 9.1.1 Asia-Pacific Analgesic Creams Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Analgesic Creams Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Analgesic Creams Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Analgesic Creams Market Size by Country
- 9.2.1 Asia-Pacific Analgesic Creams Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Analgesic Creams Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Analgesic Creams Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Analgesic Creams Sales by Country
- 10.1.1 South America Analgesic Creams Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Analgesic Creams Sales by Country (2021-2026)
- 10.1.3 South America Analgesic Creams Sales Forecast by Country (2027-2032)
- 10.2 South America Analgesic Creams Market Size by Country
- 10.2.1 South America Analgesic Creams Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Analgesic Creams Market Size by Country (2021-2026)
- 10.2.3 South America Analgesic Creams Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Analgesic Creams Sales by Country
- 11.1.1 Middle East and Africa Analgesic Creams Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Analgesic Creams Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Analgesic Creams Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Analgesic Creams Market Size by Country
- 11.2.1 Middle East and Africa Analgesic Creams Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Analgesic Creams Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Analgesic Creams Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Analgesic Creams Value Chain Analysis
- 12.1.1 Analgesic Creams Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Analgesic Creams Production Mode & Process
- 12.2 Analgesic Creams Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Analgesic Creams Distributors
- 12.2.3 Analgesic Creams Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst